Yukio Mori

453 total citations
58 papers, 381 citations indexed

About

Yukio Mori is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Yukio Mori has authored 58 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Cancer Research and 13 papers in Biochemistry. Recurrent topics in Yukio Mori's work include Carcinogens and Genotoxicity Assessment (17 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Chemical Reactions and Isotopes (8 papers). Yukio Mori is often cited by papers focused on Carcinogens and Genotoxicity Assessment (17 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Chemical Reactions and Isotopes (8 papers). Yukio Mori collaborates with scholars based in Japan, India and Sweden. Yukio Mori's co-authors include Kazumi Toyoshi, Yoichi Konishi, Toshiro Niwa, Hiroshi Yamazaki, Shigeo Baba, Kazuyuki Hirano, Masahiro Tsutsumi, Kazuhiko Uchida, Shigeyuki Sugie and Masanobu Horie and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The Journal of Organic Chemistry and International Journal of Cancer.

In The Last Decade

Yukio Mori

51 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukio Mori Japan 11 161 136 77 50 46 58 381
Kazumi Toyoshi Japan 11 135 0.8× 138 1.0× 83 1.1× 56 1.1× 48 1.0× 46 339
Margherita Ferro Italy 13 265 1.6× 118 0.9× 49 0.6× 61 1.2× 38 0.8× 28 528
Leonard E. Unruh United States 9 180 1.1× 215 1.6× 51 0.7× 76 1.5× 82 1.8× 13 417
Donald E. Nerland United States 15 188 1.2× 128 0.9× 121 1.6× 33 0.7× 44 1.0× 30 471
Irene B. Glowinski United States 10 284 1.8× 197 1.4× 56 0.7× 35 0.7× 33 0.7× 18 453
Emiko Asakawa Japan 11 188 1.2× 133 1.0× 30 0.4× 33 0.7× 60 1.3× 18 392
Ryuichi Kato Japan 10 281 1.7× 194 1.4× 182 2.4× 62 1.2× 48 1.0× 15 633
Nobuyuki Ito Japan 11 178 1.1× 177 1.3× 29 0.4× 37 0.7× 62 1.3× 14 423
Kenneth C. Morton United States 13 215 1.3× 203 1.5× 118 1.5× 72 1.4× 70 1.5× 17 510
Terence Lawson United States 10 158 1.0× 63 0.5× 55 0.7× 46 0.9× 47 1.0× 17 456

Countries citing papers authored by Yukio Mori

Since Specialization
Citations

This map shows the geographic impact of Yukio Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukio Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukio Mori more than expected).

Fields of papers citing papers by Yukio Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukio Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukio Mori. The network helps show where Yukio Mori may publish in the future.

Co-authorship network of co-authors of Yukio Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Yukio Mori. A scholar is included among the top collaborators of Yukio Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukio Mori. Yukio Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morimura, Keiichirou, et al.. (2013). The enhancing effect of ethanol on the mutagenic activation of N-nitrosomethylbenzylamine by cytochrome P450 2A in the rat oesophagus. Mutagenesis. 28(2). 161–169. 2 indexed citations
2.
Kuno, Toshiya, Yoshinobu Hirose, Yasuhiro Yamada, et al.. (2010). Chemoprevention of 1,2-dimethylhydrazine-induced colonic preneoplastic lesions in Fischer rats by 6-methylsulfinylhexyl isothiocyanate, a wasabi derivative. Oncology Letters. 1(2). 273–278. 11 indexed citations
5.
Nishikawa, Akiyoshi, Fumio Furukawa, Hwa–Young Son, et al.. (2002). Enhancement by Cigarette Smoke Exposure of 2‐Amino‐3,8‐dimethylimidazo[4,5‐ f]quinoxaline‐induced Rat Hepatocarcinogenesis in Close Association with Elevation of Hepatic CYP1A2. Japanese Journal of Cancer Research. 93(1). 24–31. 11 indexed citations
6.
Koide, Akihiro, et al.. (1999). Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 428(1-2). 165–176. 25 indexed citations
7.
Doi, Yasuko, et al.. (1999). Histological study on healing of cryocautery-inducd rat gastric ulcer treated with T-593.. Folia Pharmacologica Japonica. 113(3). 167–176. 2 indexed citations
9.
Kamano, Toshiki, Yukio Mori, Koichi Suda, et al.. (1996). Mutagenic activation ofN-nitrosobis(2-oxopropyl)amine by pancreatic juice and assessment of its ductal tumorigenicity following intraductal administration in dogs. International Journal of Pancreatology. 20(1). 51–57. 1 indexed citations
10.
Noguchi, Osamu, Kohsuke Horiguchi, Eisaku Kobayashi, et al.. (1995). Inhibitory effects of sulfation inhibitors on initiation of pancreatic ductal carcinogenesis by N-nitrosobis(2-oxopropyl)amine in hamsters. Carcinogenesis. 16(3). 457–459. 8 indexed citations
11.
Yamamoto, Kazuhiko, Masahiro Tsutsumi, Eisaku Kobayashi, et al.. (1995). Initiation of hepatocarcinogenesis by endogenously formed N-nitrosobis(2-hydroxypropyl)amine, N-nitrosodiethanolamine and N-nitroso-2,6-dimethylmorpholine in rats. Carcinogenesis. 16(11). 2633–2636. 4 indexed citations
12.
Adachi, Tetsuo, et al.. (1994). Expression of a heterodimeric (placental-intestinal) hybrid alkaline phosphatase in KB cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1218(2). 163–172. 4 indexed citations
13.
Mori, Yukio, et al.. (1993). N-Benzylimidazole, a potent inducer of rat liver enzymes involved in mutagenic activation of various carcinogens. Mutation Research Letters. 302(2). 129–133. 7 indexed citations
14.
Mori, Yukio, et al.. (1991). Absence of mutagenic action of 5β-cholan-24-oic acid derivatives in the bacterial fluctuation and standard Ames tests. Mutation Research Letters. 262(4). 267–274. 5 indexed citations
15.
Yamamoto, Kazuhiko, Akira Nakajima, Masahiro Tsutsumi, et al.. (1989). Carcinogenic activity of endogenously synthesized N-nitrosobis(2-hydroxypropyl)amine in rats administered bis(2-hydroxypropyl)amine and sodium nitrite. Carcinogenesis. 10(9). 1607–1611. 10 indexed citations
17.
Yamazaki, Hiroshi, Yukio Mori, Kazumi Toyoshi, et al.. (1986). A comparative study of the mutagenic activation of N-nitrosopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction.. PubMed. 77(2). 107–17. 6 indexed citations
18.
Mori, Yukio, Hiroshi Yamazaki, Kazumi Toyoshi, Hiroshi Maruyama, & Yoichi Konishi. (1986). Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 160(3). 159–169. 8 indexed citations
19.
Mori, Yukio, et al.. (1984). Disposition of suprofen in rats following intravenous injection.. RADIOISOTOPES. 33(3). 137–141. 1 indexed citations
20.
Mori, Yukio, Toshiro Niwa, & Kazumi Toyoshi. (1983). Mutagenic activation of selected aminoazo compounds by rat liver: evidence for a cytochrome P-448 dependent reaction.. PubMed. 74(4). 483–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026